Brind.

Merck & Co. and Hengrui Pharma outperformed the S&P 500 in recent stock returns and paid upfront license agreement charges on August 28, 2025.

1 report, 1 independent Updated Aug 28

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Merck KGaA

Keep exploring

The entities involved

Merck KGaA
German multinational science and technology company
- MSD, which operates as Merck & Co. in the US and Canada, has appointed Vidhya as Associate Vice President.Mon 12:02
- Merck KGaA filed required 13F reports with the Securities and Exchange Commission regarding institutional holdings on June 15, 2026.Mon 02:05

Coverage

Newest first; wire copies grouped

Aug 28ZacksMerck (MRK) Up 2.8% Since Last Earnings Report: Can It Continue? A month has gone by since the last earnings report for Merck (MRK). Shares have added about 2.8% in that time frame, outperforming the